LUPIN Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > lupin

Technical Analysis

Technical Strength: 2 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 44.7. According to RSI analysis, lupin is weak. 3.0 LUPIN RSI Chart
MACD (?) MACD: 1.55 and Signal Line: 3.98. According to MACD analysis, lupin is marginally weak. 3.0 LUPIN MACD Chart
Simple Moving Average (?) According to simple moving average analysis, lupin is in a downtrend. Resistance level is at 1.48e+03. 1.0 LUPIN Simple Moving Average Chart
Exponential Moving Average (?) 20-day exponential moving average just got below it's 50-day exponential moving average which is a negative signal. According to exponential moving average analysis, lupin is in a strong downtrend. Major resistance levels are 1488.081, 1488.432, 1545.132. 0.0 LUPIN Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.321. 5.0 LUPIN Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, no levels identified. NA LUPIN Fibonacci Retracement Chart
Average True Range (?) ATR: 29.6 NA LUPIN Average True Range Chart
Average Directional Index (?) ADX is 11.2 which means LUPIN is in a trading range and there is no trend. NA LUPIN Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 20, 2017
Open Price 1483.0
High Price 1488.45
Low Price 1455.25
Close Price 1465.35
Absolute Change -13.8
Percentage Change -0.933%
Weekly Change -2.07%
Monthly Change 1.35%
Yearly Change -14.7%
52-week high 1911.9
52-week low 1280.0
Corporate Actions
ExDate Purpose
July 25, 2016 AGM/DIV-RS 7.50 PER SHARE
July 21, 2014 AGM/DIV-RS 3/- PER SHARE
February 13, 2014 INT DIV-RS 3/- PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.484
Confidence in Beta0.086%
Market Capital Rs. 65967.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 63.72
TTM Price-to-Earnings (P/E) Ratio 23
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 20 January 2017: Deliverable Quantity:3.16e+05 NA LUPIN Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 20 January 2017: Daily Volatility:0.2675 NA LUPIN Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 20 January 2017: PCR_OI:0.622 PCR:0.764 NA LUPIN PCR Chart
Premium (?) 20 January 2017 Premium: -1.05 Futures OI:4022400.0 NA LUPIN Premium Chart
Option_MAX_OI (?) 20 January 2017: Price:1465.35 Put with maximum OI:1450.0 Call with maximum OI:1550.0 NA LUPIN Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 25, 2017 1464.3 4022400.0 3229.0 5301.0 1465.35
February 23, 2017 1470.3 1236800.0 997.0 2974.0 1465.35

Option Chains - NSE

LUPIN Option Zone

Announcements

January 13, 2017 LupinAllotment of Securitiesn Limited has informed the Exchange that the Allotment Committee of Directors at its meeting held on January 13, 2017 has allotted 50081 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 90,29,71,582 consisting 45,14,85,791 equity shares of Rs. 2/- each.
January 13, 2017 LupinPress Releasen Limited has informed the Exchange regarding a press release dated January 13, 2017, titled "Lupin Launches Generic MS Contin ER Tablets in the US".
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 17, 2016 November 09, 2016 interResultsr alia, to consider and take on record the unaudited financial results for the quarter ended September 30, 2016.
July 25, 2016 August 09, 2016 interResultsr alia, to consider and take on record the unaudited financial results for the quarter ended June 30, 2016.
See all Board Meetings

LUPIN is part of...

Index Weightage
NIFTY 0.88
CNX100 0.75
CNX500 0.62
CNXPHARMA 12.19

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 1418 Rs. 1436 Rs. 1451 Rs. 1470 Rs. 1484 Rs. 1503 Rs. 1517